Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

GNMX vs IDNA: Holdings Overlap & Returns

Share
Share on XDownload as PDF

GNMX and IDNA hold 35% of their weight in the same names.

askIQ about this page

askIQ about GNMX and IDNA

Net assets: $1.3m on Nov 4, 2026 for Corgi Genomics & Precision Medicine ETF, and $340m on Nov 3, 2026 for iShares Genomics Immunology and Healthcare ETF.

At a glance
31.0%
GNMX in the S&P 500
27.4%
IDNA in the S&P 500
+48.3%
GNMX total return, 6 months
+81.1%
IDNA total return, 1 year
GNMX · 6 months to Nov 4, 2026 69% of its weight is outside the S&P 500
69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · top ten 49% of the fund · 57 holdings as published by its issuer for Nov 4, 2026 · Nasdaq-100: 8% in69% of its weight is outside the S&P 50031% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.31%69%inoutside the S&P 500active share 99% · Nasdaq-100: 8% in

31% of GNMX's weight is in S&P 500 companies and 69% is outside the index. Holdings as of Nov 4, 2026.

IDNA · 1 year to Nov 4, 2026 73% of its weight is outside the S&P 500
73% of its weight is outside the S&P 50027% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.27%73%in the S&P 500of its weight outside the S&P 500active share 99% · top ten 51% of the fund · 52 holdings as published by its issuer for Nov 3, 2026 · Nasdaq-100: 8% in73% of its weight is outside the S&P 50027% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.27%73%inoutside the S&P 500active share 99% · Nasdaq-100: 8% in

27% of IDNA's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 3, 2026.

Pair scorecard

GNMX costs 0.12 points a year less; IDNA is far larger, $354m against $1.3m.

GNMX vs IDNA: Holdings Overlap & Returns
MeasureGNMXIDNA
Return
Total return, 1 yearnot published+81.1%
Drawdown
Below its all-time high16.5%, high on Sep 2, 2021
Benchmark
What it tracksGenomics and gene editingGenomics and gene editing
Cost and size
Expense ratio0.35%0.47%
Net assets$1.3m$354m
Holdings
Holdings in common35%

Method

What they share

35%

By the books each fund has filed, GNMX and IDNA hold 35% of their money in the same securities at the same weight. Holdings dated Nov 3, 2026 and Nov 4, 2026.

0 half 100%

half

35% in common

Positions both hold · largest shared weight first GNMX IDNA
Moderna Inc 11.24% 13.33%
Genmab A/S 4.39% 6.26%
Vertex Pharmaceuticals Inc 6.04% 3.29%
Revolution Medicines Inc 3.24% 3.60%
Incyte Corp 2.70% 3.18%
Twist Bioscience Corp 2.32% 5.61%
Iovance Biotherapeutics Inc 1.86% 2.98%
Caris Life Sciences Inc 1.39% 3.50%
CRISPR Therapeutics AG 1.28% 1.24%
Ideaya Biosciences Inc 1.05% 2.26%
Personalis Inc 1.18% 0.85%
Pacific Biosciences of California Inc 0.71% 0.61%
Only in one fund ↓
Only in GNMX
Thermo Fisher Scientific Inc 8.88%
Illumina Inc 3.92%
Guardant Health Inc 3.45%
10X Genomics Inc 2.87%
CareDx Inc 2.43%
GRAIL Inc 2.26%
Bio-Techne Corp 2.10%
QIAGEN NV 2.08%
Only in IDNA
REGENERON PHARMACEUTICALS 4.24%
BAYER AG 3.85%
EXELIXIS INC 3.80%
TAKEDA PHARMACEUTICAL 3.77%
MERCK & CO INC 3.32%
ROCHE PS PAR AG 3.20%
SANOFI SA 2.79%
BIONTECH SE ADR 2.73%
Check overlap with more funds →

Window by window

Window by window: GNMX vs IDNA: Holdings Overlap & Returns
Total return
WindowGNMXIDNA
3 months+24.3%+32.4%
6 months+48.3%+45.6%
1 year–+81.1%
3 years–+134.8%
Since launchNot the same days: GNMX May 2026 · IDNA Jun 2019+48.3%+88.1%

– means no data for this window. Open this comparison in the app →

Side by side

GNMX Corgi Genomics & Precision Medicine ETF · Holds 57 stocks in genomics and gene editing, 31% of its weight in S&P 500 companies IDNA iShares Genomics Immunology and Healthcare ETF · Holds 52 stocks in genomics and gene editing, 27% of its weight in S&P 500 companies
Issuer Corgi iShares
Theme Genomics and gene editing Genomics and gene editing
In the S&P 500 31.0% 27.4%
Active share vs the S&P 500 99.4% 99.1%
In the Nasdaq-100 7.7% 7.5%
Holdings 57 52
Top ten, share of the fund 49.2% 51.3%
Expense ratio 0.35% 0.47%
Fee for the differing part 0.35% 0.47%
Total return, 1 year +48.3% (since launch, May 6, 2026) +81.1%
vs its benchmark not measured not measured
Below its high −4.2% −16.5%
Net assets, GNMX as of Nov 4, 2026 and IDNA as of Nov 3, 2026 $1.3m $340m

As of Nov 4, 2026. Source: ETFIQ.

35% of the two portfolios are the same securities at the same weight.

Alert

IDNA flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
GNMX

By weight, 31% of GNMX's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 49% of the fund across 57 positions, as published by its issuer for Nov 4, 2026. Since it first traded on May 6, 2026 the fund returned +48.3% with distributions reinvested.

IDNA

By weight, 27% of IDNA's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 51% of the fund across 52 positions, as published by its issuer for Nov 3, 2026. Over the year to Nov 4, 2026 the fund returned +81.1% with distributions reinvested. It sits 16.5% below its all-time high of Sep 2, 2021.

Questions people ask

Do GNMX and IDNA hold the same stocks?
By their latest filings, 35% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, GNMX or IDNA?
GNMX has 31% of its weight in S&P 500 names and IDNA has 27%, so GNMX differs more from the index.
Which is cheaper, GNMX or IDNA?
GNMX charges 0.35% a year and IDNA charges 0.47%, so GNMX is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, GNMX against IDNA, data as of Nov 4, 2026. https://etfiq.com/compare/themes/gnmx-vs-idna

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.